Negative impact of anorexia and weight loss during prior pirfenidone administration on subsequent nintedanib treatment in patients with idiopathic pulmonary fibrosis
出版年份 2019 全文链接
标题
Negative impact of anorexia and weight loss during prior pirfenidone administration on subsequent nintedanib treatment in patients with idiopathic pulmonary fibrosis
作者
关键词
Nintedanib, Pirfenidone, Early termination, Adverse event, Anorexia, Weight loss
出版物
BMC Pulmonary Medicine
Volume 19, Issue 1, Pages -
出版商
Springer Nature
发表日期
2019-04-11
DOI
10.1186/s12890-019-0841-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial
- (2018) Carlo Vancheri et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Clinical Significance of Body Weight Loss in Idiopathic Pulmonary Fibrosis Patients
- (2018) Yoshinari Nakatsuka et al. RESPIRATION
- Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis
- (2017) Steven D Nathan et al. Lancet Respiratory Medicine
- Idiopathic pulmonary fibrosis
- (2017) Fernando J. Martinez et al. Nature Reviews Disease Primers
- Low body surface area predicts hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosis
- (2017) Satoshi Ikeda et al. Scientific Reports
- Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis
- (2016) Paola Rogliani et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis
- (2016) Steven D Nathan et al. THORAX
- An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline
- (2015) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Switching to nintedanib after discontinuation of pirfenidone due to adverse events in IPF
- (2015) Katrin Milger et al. EUROPEAN RESPIRATORY JOURNAL
- Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis
- (2014) Takashi Ogura et al. EUROPEAN RESPIRATORY JOURNAL
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive assessment of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis
- (2014) Dominique Valeyre et al. RESPIROLOGY
- The INPULSIS enigma: exacerbations in idiopathic pulmonary fibrosis
- (2014) Samy Suissa et al. THORAX
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
- (2012) Y Kanda BONE MARROW TRANSPLANTATION
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
- (2011) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search